Renaissance Group’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.75M Sell
96,839
-1,475
-2% -$125K 0.36% 82
2026
Q1
$8.22M Buy
98,314
+18,837
+24% +$1.55M 0.34% 91
2025
Q4
$7.28M Sell
79,477
-1,017
-1% -$97.4K 0.29% 92
2025
Q3
$7.63M Buy
80,494
+6,539
+9% +$615K 0.29% 96
2025
Q2
$7.75M Buy
73,955
+17,144
+30% +$1.63M 0.3% 78
2025
Q1
$5.02M Buy
56,811
+10,071
+22% +$1.03M 0.22% 93
2024
Q4
$4.49M Buy
46,740
+4,838
+12% +$451K 0.19% 101
2024
Q3
$3.43M Buy
41,902
+2,882
+7% +$222K 0.14% 117
2024
Q2
$3.36M Buy
39,020
+3,814
+11% +$308K 0.13% 133
2024
Q1
$2.87M Buy
35,206
+7,374
+26% +$576K 0.11% 144
2023
Q4
$1.85M Buy
+27,832
New +$1.93M 0.08% 175
2021
Q1
Sell
-17,295
Closed -$1.21M 288
2020
Q4
$1.21M Buy
17,295
+620
+4% +$38.6K 0.05% 125
2020
Q3
$857K Buy
16,675
+5,424
+48% +$298K 0.04% 134
2020
Q2
$660K Buy
11,251
+99
+0.9% +$5.47K 0.03% 167
2020
Q1
$564K Buy
11,152
+796
+8% +$52.9K 0.03% 179
2019
Q4
$767K Buy
10,356
+2,665
+35% +$166K 0.03% 173
2019
Q3
$440K Buy
+7,691
New +$510K 0.02% 212

Other funds holding HQY

Renaissance Group's HQY Position: Q2 2026 in Review

Renaissance Group reduced its HealthEquity (HQY) stake by 1.5% in Q2 2026, selling an estimated $125K and leaving 96,839 shares worth $8.75M. The position accounts for 0.36% of the portfolio, ranked #82.

Renaissance Group first reported a position in HQY in Q3 2019 and has held it in 17 quarters since. 498 funds tracked by Wall St. Rank hold HQY as of Q2 2026.

  • Renaissance Group held 96,839 shares of HealthEquity worth $8.75M as of Q2 2026.
  • Renaissance Group sold 1,475 HealthEquity shares in Q2 2026, an estimated $125K.
  • HealthEquity made up 0.36% of Renaissance Group's portfolio in Q2 2026, its #82 holding.
  • Renaissance Group first reported a position in HealthEquity in Q3 2019 and has held it in 17 quarters since.
  • 498 funds tracked by Wall St. Rank held HealthEquity as of Q2 2026.

Based on Renaissance Group's 13F filing for Q2 2026, filed 13 Aug 2026.